Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elman Retina Group is a specialized ophthalmic practice and clinical research center focused on the diagnosis and treatment of diseases affecting the retina, macula, and vitreous. Founded by Dr. Michael J. Elman, the group operates multiple state-of-the-art facilities in the Baltimore metropolitan area. Beyond providing advanced clinical care, the organization is a nationally recognized site for multicenter clinical trials, participating in Phase 1 through Phase 4 studies for novel retinal therapies. They have been instrumental in the clinical development of major ophthalmic drugs, partnering with both private industry and government-funded research networks like the DRCR.net. Their expertise spans conditions such as age-related macular degeneration, diabetic eye disease, and complex retinal surgeries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elman Retina Group.